Semax + Selank

Russia-approved cognitive + anxiolytic neuropeptide stack. Semax (ACTH analog) drives BDNF and cognitive enhancement. Selank (tuftsin analog) modulates GABA-A for anxiolytic effects without sedation. Complementary mechanisms for cognitive research.

CognitiveAnxiolyticSemax BDNFSelank GABAIntranasal / InjectableRussia-Approved

QUICK FACTS

SEMAXACTH(4-7) analog — BDNF upregulation, cognitive

SELANKTuftsin analog — GABA-A modulation, anxiolytic

SYNERGYCognitive enhancement + anxiety reduction combined

APPROVALBoth approved in Russia for cognitive / anxiety

ROUTEIntranasal or injectable — both available

Overview

The Semax + Selank combination pairs two Russian-approved neuropeptides with complementary cognitive mechanisms. Semax is an ACTH(4-7) analog that stimulates BDNF production and activates dopaminergic and serotonergic pathways — producing cognitive enhancement, neuroprotection, and stroke recovery effects. Selank is a tuftsin analog that modulates GABA-A receptors, producing anxiolytic effects without sedation, memory consolidation support, and stress resilience. Together they address cognitive performance (Semax) and anxiety reduction (Selank) — a combination used in Russian clinical practice for stress, anxiety, and cognitive disorders. The stack is of particular interest because the anxiolytic component addresses anxiety that can impair cognitive function, while Semax directly enhances cognitive performance.

Research Areas

ACTH analog pharmacologyBDNF pathway researchGABAergic anxiolytic researchCognitive enhancement researchNeuropeptide combination researchStress and anxiety research

Available Evidence

Russia-Approved (Both)Semax and Selank are both approved medications in Russia for cognitive and anxiety indications. Clinical use data from approved indications available.

MechanisticBDNF upregulation (Semax) and GABA-A modulation (Selank) well-characterized. Complementary CNS mechanisms documented.

Combination ResearchAmplitude of cognitive effect + anxiety reduction via complementary pathways. Stack widely researched in combination.

Documented Research Benefits

BDNF upregulation

Semax

Anxiolytic without sedation

Selank

Cognitive enhancement

Semax clinical

Memory consolidation

Selank

Neuroprotection

Semax

Combined CNS stack

synergistic

What are you researching?

Tell us your focus area and we’ll send a personalized research guide.

Safety & Regulatory Status

Both compounds have approved clinical use in Russia. Generally well-tolerated. Not FDA-approved. Monitor for sedation-like effects. All information educational reference only.